Ketamine Improves Anhedonic Phenotypes Across Species: Translational Evidence From the Probabilistic Reward Task

Ketamine is increasingly used as a therapeutic option for treatment-resistant depression (TRD) due to its rapid antidepressant properties, yet the mechanisms underlying these effects remain elusive. Preclinical evidence suggests ketamine acts on neural pathways implicated in reward processing, but translational efforts have proven challenging, due to a lack of paradigms allowing for analogous assessment of depressive phenotypes across species. We investigated the effects of a single, subanesthetic dose of ketamine on reward responsiveness in individuals with TRD (0.5mg/kg) and chronically-stressed rats (10mg/kg) using functionally identical tasks. Humans completed the Probabilistic Reward Task (PRT) twice within 48h, either without intervention (healthy controls, n=36, 26 women) or 24h before and after ketamine administration (individuals with TRD, n=24, 16 women). Rats (all male) completed a reverse-translated version of the PRT on three consecutive days (healthy controls, n=10) or before and after chronic stress exposure as well as 2h and 24h after ketamine administration (experimental group, n=10). Ketamine significantly increased response bias toward the more frequently rewarded stimulus in both species, resulting in levels comparable to healthy controls 24h post-administration. Exploratory analyses in humans suggested that this effect was strongest among individuals with more pronounced baseline anhedonia. Furthermore, in both species, ketamine had no effect on measures of discriminability, suggesting ketamine selectively improved reward learning rather than overall task performance. Results highlight a shared behavioral mechanism through which ketamine alleviates anhedonic behaviors and offers important implications for the treatment of people suffering from anhedonia in TRD and related psychopathologies.